These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 162677)

  • 1. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.
    Magnus RV
    J Int Med Res; 1975; 3(3):207-13. PubMed ID: 162677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
    Petrie WM; McEvoy JP; Wilson WH; Ban TA; Guy W
    Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
    McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
    Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind trial: vivalan against placebo in depressed elderly patients.
    Von Knorring L
    J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viloxazine: an assessment of its potential rapid antidepressant action and unwanted effects.
    Edwards JG
    Curr Med Res Opin; 1977; 5(3):226-33. PubMed ID: 162658
    [No Abstract]   [Full Text] [Related]  

  • 8. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness.
    Sedman G
    Curr Med Res Opin; 1977; 5(3):217-25. PubMed ID: 162657
    [No Abstract]   [Full Text] [Related]  

  • 10. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does viloxazine have epileptogenic properties?
    Edwards JG; Glen-Bott M
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):960-4. PubMed ID: 6434699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
    León CA; Vigoya J; Conde S; Campo G; Castrillón E; León A
    Acta Psiquiatr Psicol Am Lat; 1994 Mar; 40(1):41-9. PubMed ID: 8053353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.